Navigation Links
Guardian Survey: Men are Twice as Likely as Women to Use Credit Cards to Pay for Major Health Expenses
Date:9/10/2008

their financial lives and improve employee recruitment, retention and satisfaction by maximizing the use and power of their workplace coverage. Five reports currently available in the series include:

-- Benefits & Behavior: Spotlight on Group Critical Illness Insurance

-- Benefits & Behavior: Spotlight on Group Medical

-- Benefits & Behavior: Spotlight on Dental

-- Benefits & Behavior: Spotlight on Group Life and Disability Insurance

-- Benefits & Behavior: The Voice of American Business Owners and Benefit

Decision Makers Today

The reports can be found at http://www.GuardianBenefits.com.

About the Survey

The Opinion Research Corporation of Princeton, New Jersey, conducted this omnibus consumer survey for Guardian. The survey sample consists of 1,000 individuals who are at least 18 years of age. They were interviewed by telephone from April 17 to 20, 2008. The margin of error was plus or minus 3.1 percentage points at the 95% confidence level.

About Guardian

Founded in 1860, The Guardian Life Insurance Company of America, New York, NY (Guardian) is one of the largest mutual life insurance companies in the United States. As of December 31, 2007, Guardian and its subsidiaries had $41.3 billion in assets (on a consolidated statutory basis). With close to 3,000 financial representatives and 80 agencies nationwide, Guardian and its subsidiaries protect individuals, small business owners, and their employees with life, disability, health, long-term care, critical illness and dental insurance products, and offer 401(k), annuities, and other financial products and trust services. Specializing in the small to mid-size business market, Guardian's Group business unit serves more than 120,000 employers, 6 million employees, and their families. More information about Guardian can be obtained at: '/>"/>

SOURCE The Guardian Life Insurance Company of America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Guardians Dental Network Experiences Double-Digit Growth
2. Guardian Introduces New Program to Help Employers Control Health Care Premiums
3. Guardian of genome predicts treatment outcomes for childhood cancer
4. Evolution of human genomes guardian gives people unique protections from DNA damage
5. Target Data Research Sponsors Forgotten Citizens Who Are in Need of Public Guardianship To Support and Manage Their Healthcare and Personal Needs
6. Home Guardian Releases Innovative Sensor System to Keep Seniors Safe
7. Guardian Expands Dental Benefit Options Helps Small Business Owners Lower Insurance Cost
8. Guardian Survey: Despite Perceived Effectiveness, Most Employees Who Participate in Wellness Programs Do Not Stay Committed
9. ACORN Expands Presence in EDC Market with Commercialization of Guardian EDC(TM)
10. Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement
11. Guardian Survey: Fear of Losing Income Due to the Economy Equals Fear of Losing Income Due to Disability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ass., Jan. 8 CrossTech Forums toda...ght , the only national invitational summit featur...ights, an IDC company, will now take place at the ...l 29-May 1, 2009. Originally scheduled for January...four-diamond Phoenix resort in order to accommodat...
(Date:1/8/2009)..., N.J., Jan. 8 Pharmasse...t will present at the 27th Annual JPMorgan Healthc...009 at the Westin St Francis in San Francisco, CA....Executive Officer, will provide an overview of the..., 2009 at 9:00 AM (PT). , , To access a simult...
(Date:1/8/2009)...GO and GREENSBURG, Pa., Jan. 8 /PRNewswire-FirstCa...lth, a non-profit health care network serving,Wes...erprise Electronic Health,Record (EHR) for the mo...alth,Physician Practices (EHPP). , (Logo: ...041LOGO ) , Excela Health, serving residen...
(Date:1/8/2009)...19 Session in Orlando Will Feature Strategies ...Loyalty and Plan Profitability , , WOBURN, Mas...marketplace disruption - ranging from the employme...onsumer autonomy in health insurance selection - t...mbers is now a priority for the nation,s health in...
Breaking Medicine News(10 mins):Health News:CrossTech Forums Announces Health IT Insight 2009 Moving to Arizona Grand Resort in Phoenix; Executive Summit to Take Place April 29-May 1 2Health News:CrossTech Forums Announces Health IT Insight 2009 Moving to Arizona Grand Resort in Phoenix; Executive Summit to Take Place April 29-May 1 3Health News:Pharmasset to Present at the 27th Annual JPMorgan Healthcare Conference 2Health News:Pharmasset to Present at the 27th Annual JPMorgan Healthcare Conference 3Health News:Excela Health Selects Allscripts Electronic Health Record for Physicians 2Health News:Excela Health Selects Allscripts Electronic Health Record for Physicians 3Health News:Excela Health Selects Allscripts Electronic Health Record for Physicians 4Health News:Excela Health Selects Allscripts Electronic Health Record for Physicians 5Health News:World Health Care Congress and ConnextionsHealth Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 2Health News:World Health Care Congress and ConnextionsHealth Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 3
...tant TB could create an "apocalyptic scenario" if ...n 30,000 people.. The new plan from WHO and the S...eeded to slow the spread of multi-drug resistant T... or XDR-TB. The new plan will cost 2.5 billion as ...
...er this month whether internet and video game addi... the issue at the AMA national meeting at Chicago....oling up in their rooms, ignoring friends, family,..., while grades plummet and belligerence soars. Vid...
...s could be the difference between living or dying ...ch indicates . A study published in the online edi...d that omega-3 fatty acids found in the foods may ...isposition to the condition. Working with mice gen...
...nts higher, on average, than their younger sibling...s that its how the kids are raised, not their birt...esearchers who authored the report, published in t...he investigators found that children raised as the...
Other Medicine News:Health News:Plan to Contain Drug Resistant TB Launched-WHO 2Health News:Video Game Addiction to Be Termed as a Medical Condition 2Health News:First-borns Have Higher IQs Than Their Younger Siblings 2
(Date:1/7/2009)...an. 7 Eli Lilly and Comp...ed a complete response letter from,the U.S. Food ...acting,injection (LAI) for acute and maintenance ...ntinuing to work with the agency on the new drug,...re any additional clinical trials for the continue...
(Date:1/7/2009).... 7 ImQuest Life Sciences announce...ation to the Food and Drug Administration to initi...edione HIV inhibitor IQP-0410. ImQuest anticipates...rter of 2009. IQP-0410 is a novel small molecule i...oside reverse transcriptase inhibitor (NNRTI). The...
(Date:1/7/2009)..., January 7 Circassia Ltd, a speci... and critical care, today,announced that followin...h,its ToleroMune(R) anti-allergy technology, the ... a further phase II clinical trial in cat allergy....uited 120 patients with confirmed,cat allergies, ...
(Date:1/6/2009)... 6 In recent controlled studies co...phis , scientists found that the patented ingredie...d only proven ingredient to increase levels of nit...od nitrate/nitrate (NOx) in human subjects. , ,... increase in blood flow to the skeletal muscles. ...
Breaking Medicine Technology:FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Clot Dissolver Doesnt Boost Survival in Cardiac Arrest Patients 32511 1Clot Dissolver Doesnt Boost Survival in Cardiac Arrest Patients 32511 2Clot Dissolver Doesnt Boost Survival in Cardiac Arrest Patients 32511 3Doctors Describe First U S Face Transplant 32509 1Doctors Describe First U S Face Transplant 32509 2Doctors Describe First U S Face Transplant 32509 3Doctors Describe First U S Face Transplant 32509 4No quick or easy technological fix for climate change researchers say 6369 1No quick or easy technological fix for climate change researchers say 6369 2No quick or easy technological fix for climate change researchers say 6369 3No quick or easy technological fix for climate change researchers say 6369 4High blood sugars impact on immune system holds clues to improving islet cell transplants 6367 1High blood sugars impact on immune system holds clues to improving islet cell transplants 6367 2High blood sugars impact on immune system holds clues to improving islet cell transplants 6367 3
...laxoSmithKline today,announced results from ongoin...astatic renal cell carcinoma (RCC), ovarian cancer...presented at the,43rd Annual Meeting of the Americ... The results observed in these trials with,pazopan...an oral, investigational angiogenesis inhibitor,ta...
...swire/ -- (SEND2PRESS,NEWSWIRE) -- Epeius Biotechn...n of a historic landmark in medical oncology and a...cer gene therapy.,The first clinical report of its... issue of the International Journal of,Oncology, V...eatures of tumor destruction observed in chemo-res...
Other Medicine Technology:GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 3
All BioWhittaker Cell Culture Reagent and Buffer products are manufactured in accordance with cGMP regulations and are cell culture tested to assure compatibility. , Typical Properties, Sterility :
All BioWhittaker Cell Culture Reagent and Buffer products are manufactured in accordance with cGMP regulations and are cell culture tested to assure compatibility. , Typical Properties, Sterility :
GENTAMICIN SULFATE, 1000X
Gentamicin Sulphate : Antibiotic that inhibits normal protein synthesis. USBio analysed. Autoclavable.
Medicine Products: